The choice of neoadjuvant treatment of menopausal patients with locally advanced chemoresistant luminal breast cancerAuthors: Smolanka I.I. Ivankova V.S. Movchan O.V. Ivankova O.M.... Т. 14, №3 (55)
Prediction the oncoepidemiological process developments in Ukraine and researching its components in conditions by the COVID-19 Global pandemicAuthors: Michailovich Yu. Gorokh Ye. Ryzhov A. Т. 14, №3 (55)
Features of immune microenvironment in Her2 low breast cancerAuthors: Lyalkin S.A. Krotevich M.S. Smolanka I.I. Shudrak P.A.... Т. 14, №3 (55)
Neoadjuvant Chemotherapy in the Comprehensive Treatment of Patients with Stage III–IV Ovarian CancerAuthors: Hrytsyk R. Kryzhanivska A. Т. 14, №3 (55)
Influence a vacuum-assisted closing of defects of malignant tumors of skin after an epidermization on local recurrence-free survivabilityAuthors: Ostafiichuk V.V. Dedkov А.G. Korovin S.I. Kukushkina M.M.... Т. 14, №3 (55)
Reduction of the incidence of hepatocellular carcinoma by vaccination from the hepatitis B virusAuthors: Patsko V. Cherchenko K. Ostapenko Y. Lukashenko A. Т. 14, №3 (55)
Zirabev as a representative of the largest family of biosimilars in oncology
Management of immunotherapy toxicity: European Society for Medical Oncology (ESMO) clinical guidelines for diagnosis, treatment and patient follow-up
Two-stage hepatectomy in resection of bilobar colorectal liver metastases: surgical outcomes and prognostic factorsAuthors: Mykytyuk A. Burlaka A. Lukashenko A. Beznosenko A.... Т. 14, №3 (55)
Simultaneous thrombectomy from pulmonary artery branches and inferior vena cava for left adrenocortical carcinomaAuthors: Skums A.V. Gabrielyan A.V. Gurin P.V. Symonov O.M.... Т. 14, №3 (55)
Neoadjuvant endocrine therapy of breast cancer: history and modern views of the problem
Authors: Zavizion V.F. Artemenko M.V. Т. 14, №3 (55)
Authors: Zavizion V.F. Artemenko M.V. Т. 14, №3 (55)
An updated systematic review, meta-analysis and network meta-analysis of the clinical benefit and safety of gemtuzumab ozogamicin in treating acute myeloid leukemia in various subgroups
Relationship of special molecular mechanisms in colorectal cancer. Literature reviewAuthors: Pokitko O.V. Sulayeva O.M. Mashukov A.O. Merlich S.V.... Т. 14, №2 (54)
The era of «targets» in the treatment strategy of resectable NSCLC: from ADAURA to NeoADAURA…Т. 14, №2 (54)
New opportunities in first-line therapy of unresectable EGFRm NSCLC. Overview of clinical trials FLAURA, FLAURA2, LAURAТ. 14, №2 (54)
